---
layout: post
title: 過去八年有關冠狀病毒的GoF研究
date: 2020-08-14 21:33:33.000000000 +00:00
categories: vocus
tags: blog
author: ecyY
---

<p>前天 (8月12日)，期刊BioEssays刊登了一份由Sirotkin & Sirotkin (2020) 的文章，內容回顧了過去八年有關冠狀病毒的GoF研究，引述了幾篇在這八年間刊登的文章，對了解冠狀病毒的GoF研究發展有很大幫助。</p>
<p>所謂GoF研究，是指 Gain-of-Function Research，根據NCBI (2020) 的定義，任何涉及基因型及其表型改變的選擇過程就是一項GoF研究。(”any selection process involving alteration of genotypes and their resulting phenotypes is considered a type of Gain-of-Function (GoF) research”)。</p>
<p>Potential Risks and Benefits of Gain-of-Function Research<br>
Summary of a Workshop</p>
<p>文章介紹，早在2013年，Ge et al. (2013) 已於自然期刊發表文章，提到團隊成功從野生蝙蝠中分離出冠狀病毒，為一種靶向ACE2受體的冠狀病毒基因組的GOF研究奠定了基礎，項目的部份資金來自EcoHealth Alliance。Aizenman (2020) 更加發現在過去幾年，研究人員從蝙蝠中已分離出多達400種的冠狀病毒。</p>
<p>在隨後的幾年，EcoHealth Alliance獲得了一項有關冠狀病毒的GoF項目的研究經費，項目名為「UNDERSTANDING THE RISK OF BAT CORONAVIRUS EMERGENCE」，研究時間為2014年6月1日至2019年5月31日，據引述該項目是利用以下技術“[spike]‐protein sequence data, infectious clone technology, in vitro and in vivo infection experiments and analysis of receptor binding”來處理蝙蝠冠狀病毒基因組 (NIH, 2014)。</p>
<p>至2015年，一篇由Menachery et al. (2015) 題為 ”A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence”的文章，成功利用反轉基因法 (reverse genetics system) 研製出一種嵌合病毒 SHC014：”a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone”，結果顯示它能更有效在人類氣道複製：”The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), <strong>replicate efficiently in primary human airway cells </strong>and achieve <em>in vitro </em>titers equivalent to epidemic strains of SARS-CoV”</p>
<p>這些研究對我們今天了解COVID-19的傳播有重要的參考價值。</p>
<p><br></p>
<p>參考</p>
<p>Aizenman, N. (2020) New Research: Bats Harbor Hundreds Of Coronaviruses, And Spillovers Aren't Rare, Feb 20. <a href="https://www.npr.org/sections/goatsandsoda/2020/02/20/807742861/new-research-bats-harbor-hundreds-of-coronaviruses-and-spillovers-arent-rare">https://www.npr.org/sections/goatsandsoda/2020/02/20/807742861/new-research-bats-harbor-hundreds-of-coronaviruses-and-spillovers-arent-rare</a></p>
<p>Ge, X., Li, J., Yang, X., A.A. Chmura, G. Zhu, J. H. Epstein, J. K. Mazet, B. Hu, W. Zhang, C. Peng, Y. J. Zhang, C. M. Luo, B. Tan, N. Wang, Y. Zhu, G. Crameri, S. Y. Zhang, L. F. Wang, P. Daszak, Z. L. Shi (2013) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, <em>Nature </em><strong>503, </strong>535–538. https://doi.org/10.1038/nature12711</p>
<p>Menachery, V.D., Yount, B.L., Jr.,K. Debbink, S. Agnihothram, L. E. Gralinski, J. A. Plante, R. L. Graham, T. Scobey, X. Y. Ge, E. F. Donaldson, S. H. Randell, A. Lanzavecchia, W. A. Marasco, Z. L. Shi, R. S. Baric (2015)  <a href="https://idp.nature.com/authorize/casa?redirect_uri=https://www.nature.com/nm/journal/v21/n12/full/nm.3985.html&casa_token=9spW52Q20OIAAAAA:lLPYO8v2S1_BUt77TZXuyYdhBb81WpmPjHyzmVYw9u3x4RmwBXsMhFwb8x651ojziZv_QD_4f62jFwP6Pw"><u>A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence</u></a><u>, </u><em>Nat. Med. </em>21, 1508</p>
<p>NCBI (2020) Potential Risks and Benefits of Gain-of-Function Research: Summary of a Workshop, NCBI. <a href="https://www.ncbi.nlm.nih.gov/books/NBK285579/">https://www.ncbi.nlm.nih.gov/books/NBK285579/</a></p>
<p>NIH (2014) Understanding the Risk of Bat Coronavirus Emergence, <em>National Institutes of Health</em>, U.S. Department of Health and Human Services. <a href="http://projectreporter.nih.gov/project_info_description.cfm?aid=8674931&icde=49750546">projectreporter.nih.gov/project_info_description.cfm?aid=8674931&icde=49750546</a></p>
<p>Sirotkin, K. & Sirotkin, D. (2020) Might SARS‐CoV‐2 Have Arisen via Serial Passage through an Animal Host or Cell Culture? BioEssays,  https://doi.org/10.1002/bies.202000091</p>
<p><br></p>
